Consensus statement on childhood tuberculosis

    Indian Pediatrics
    |February 9, 2010
    PubMed

    Insights

    This consensus statement provides standardized diagnostic and treatment protocols for childhood tuberculosis (TB). It emphasizes clinical suspicion, targeted investigations like Mantoux tests and AFB analysis, and categorized treatment regimens for improved pediatric TB management.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Public Health

    Background:

    • Current tuberculosis (TB) control programs primarily focus on adults, with limited tools for diagnosing childhood TB.
    • Standardization of diagnostic and management protocols for pediatric tuberculosis is urgently needed.
    • The Revised National Tuberculosis Control Program (RNTCP) lacks specific guidelines for children.

    Purpose of the Study:

    • To develop standardized recommendations and protocols for accurate diagnosis of childhood tuberculosis.
    • To establish rational treatment guidelines for pediatric TB cases.
    • To provide a consensus statement on childhood TB management.

    Main Methods:

    • A Working Group was established by the Indian Academy of Pediatrics to review existing literature on childhood TB.
    • Consensus was developed through group deliberations and circulation of draft recommendations to members for review.
    • Efforts were made to ensure standardization of all proposed recommendations.

    Main Results:

    • Suspicion of TB in children should be based on prolonged fever/cough, weight loss, and contact history.
    • Recommended diagnostic steps include Chest X-ray, Mantoux test, and Acid-Fast Bacilli (AFB) detection in sputum or gastric aspirate.
    • Treatment is categorized into three groups based on disease type and prior treatment, with intermittent, higher-dose therapy recommended for DOTS.

    Conclusions:

    • Standardized diagnostic criteria and treatment protocols are essential for effective childhood TB management.
    • Clinical suspicion combined with targeted investigations like AFB and Mantoux testing aids in diagnosis.
    • Categorized treatment and adherence monitoring are crucial for successful outcomes in pediatric TB.
    Abstract

    Related Concept Videos

    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    Tuberculosis01:23

    Tuberculosis

    Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...